<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7267122\results\search\drug\results.xml">
  <result pre="SARSâ€�CoVâ€�2019 2019 Novel Coronavirus TEN Toxic Epidermal Necrolysis TMSP Transmembrane" exact="Serine" post="Protease 1 INTRODUCTION The initial outbreak of the novel"/>
  <result pre="hygiene: Washing hands with sanitizers containing a high concentration of" exact="ethanol" post="can inactivate the virus.28 Consistent cleaning of environmental surfaces"/>
  <result pre="(TEN), Colitis haemorrhage etc. Atleast three trials (eg, NCT04303299 3/12/2020)" exact="Chloroquine" post="Interferes with the cellular receptor ACE2 and also impairs"/>
  <result pre="etc. At least ten trials (eg, NCT04303507, 3/11/20; NCT04261517, 2/14/20)" exact="Ribavirin" post="Nucleoside analog of ribofuranose that inhibits viral RNA synthesis"/>
  <result pre="transaminase Two trials (NCT04260594,2/7/20; NCT04286503, 2/27/20) 4.1 Lopinavir/ritonavir Lopinavir and" exact="ritonavir" post="are protease inhibitors that work in conjunction to block"/>
  <result pre="lopinavir, thus boosting its levels. A 4 ug/mL concentration of" exact="lopinavir" post="was required for in vitro antiviral activity against SARS"/>
  <result pre="for in vitro antiviral activity against SARS while 1ug/mg of" exact="lopinavir" post="was enough when used in combination with ribavirin.30 Both"/>
  <result pre="might be required for efficacy.20 Nevertheless, lopinavir/ritonavir is advantageous over" exact="ribavirin" post="because of its wide availability and an established toxicity"/>
  <result pre="vitro at a concentration of 10 to 30â€‰Î¼M.34, 36 4.6" exact="Chloroquine" post="Chloroquine, generally used for amebiasis and malaria, is currently"/>
  <result pre="acidification of endosomes, thereby impeding virus trafficking inside cells. Although" exact="chloroquine" post="has been unsuccessful in treatment of SARSâ€�infected mice,37 recent"/>
  <result pre="SARSâ€�infected mice,37 recent reports from in vitro data show that" exact="chloroquine" post="inhibits SARSâ€�CoVâ€�2 at a 50% inhibitory concentration of 1"/>
  <result pre="worth mentioning that for SARS, the 50% inhibitory concentration of" exact="chloroquine" post="is near to 9 uM,39 implying chloroquine is more"/>
  <result pre="inhibitory concentration of chloroquine is near to 9 uM,39 implying" exact="chloroquine" post="is more potent against SARSâ€�CoVâ€�2 than SARS. Studies of"/>
  <result pre="chloroquine is more potent against SARSâ€�CoVâ€�2 than SARS. Studies of" exact="chloroquine" post="and hydroxychloroquine are underway.40, 41, 42, 43 At the"/>
  <result pre="more potent against SARSâ€�CoVâ€�2 than SARS. Studies of chloroquine and" exact="hydroxychloroquine" post="are underway.40, 41, 42, 43 At the same time,"/>
  <result pre="potential drugs Several other potential drugs include BCRâ€�ABL kinase inhibitor" exact="imatinib" post="and Typeâ€�II transmembrane serine protease (TMSPSS2) inhibitors.44 Imatinib inhibits"/>
  <result pre="disulfiram, chalcone, ebselen, tideglusib, carmofur, PX12, shikonin, TDZDâ€�8, cinanserin, and" exact="cyclosporin A." post="Also, some Chinese herbal medicines such as Radix Sophorae"/>
  <result pre="SARSâ€�CoVâ€�1. N Engl J Med. 2020;382:1564â€�1567. 10.1056/NEJMc2004973.32182409 28KampfG. Efficacy of" exact="ethanol" post="against viruses in hand disinfection. J Hosp Infect. 2018;98(4):331â€�338.28882643"/>
  <result pre="Chem Chemother. 2006;17(5):275â€�284.17176632 38WangM, CaoR, ZhangL, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019â€�nCoV) in"/>
  <result pre="in vitro. Cell Res. 2020;30(3):269â€�271.32020029 39Alâ€�BariMA. Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
  <result pre="emerging viral diseases. Pharmacol Res Perspect. 2017;5(1). 40ColsonP, RolainJM, RaoultD." exact="Chloroquine" post="for the 2019 novel coronavirus. Int J Antimicrob Agents."/>
  <result pre="Int J Antimicrob Agents. 2020;15:105923. 41ColsonP, RolainJM, LagierJC, BrouquiP, RaoultD." exact="Chloroquine" post="and hydroxychloroquine as available weapons to fight COVIDâ€�19. Int"/>
  <result pre="Antimicrob Agents. 2020;15:105923. 41ColsonP, RolainJM, LagierJC, BrouquiP, RaoultD. Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVIDâ€�19. Int J Antimicrob"/>
  <result pre="Int J Antimicrob Agents. 2020;55(4):105932.32145363 42GautretP, LagierJC, ParolaP, et al." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVIDâ€�19: results of"/>
  <result pre="Antimicrob Agents. 2020;55(4):105932.32145363 42GautretP, LagierJC, ParolaP, et al. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVIDâ€�19: results of an openâ€�label"/>
  <result pre="43SahraeiZ, ShabaniM, ShokouhiS, SaffaeiA. Aminoquinolines Against Coronavirus Disease 2019 (COVIDâ€�19):" exact="Chloroquine" post="or Hydroxychloroquine. Int J Antimicrob Agents. 2020;16:105945. 44HoffmannM, Kleineâ€�WeberH,"/>
 </snippets>
</snippetsTree>
